Stop buying and selling blindly, and start investing like Warren Buffett does. In Mycroft's Blue Book Stock Guide 2014, Mycroft Psaras gives you the market advantage by providing detailed analysis derived from the formula that helped make Warren Buffett and Charlie Munger billionaires. Whether you're a vice or a seasoned pro, any investor's tool box is incomplete without this straightforward, accessible database. Mycroft presents major quantitative analysis on 2,554 stocks, analyzed with buy, hold, sell, and short opinions and supported with powerful back-tested ratios. Preceding the database is a thorough walk-through of need-to-kw industry terms, including free cash flow, net income, depreciation, and amortization. He then explains how these interact with each other within the market and its analysis. Prior to purchasing a stock, many investors have little idea or interest in the true valuation of a company. Mycroft designed Mycroft's Blue Book Stock Guide 2014 to be used as a reference guide for deriving an accurate, straightforward valuation of a company and giving investors the upper hand on other market participants. Mycroft presents his research in a straightforward, -frills manner that is accessible to both the vice and seasoned investor. Its purpose is the same as a consumer guide for purchasing a television or a vehicle. It's meant to help investors make their own decisions about where to put their money. It is a starting point in performing your own due diligence on a company.
Mycroft Psaras is a qualitative and quantitative equity analyst and also serves as CEO and portfolio manager for SIA Capital Management Inc. and Mycroft Research LLC (two registered investment advisory firms). In his book, Mycroft's Blue Book Stock Guide 2014, he takes a straightforward approach to arming new and seasoned investors with his cutting edge analysis, derived from studying the theories of financial icons Warren Buffett and Charlie Munger. His hope in writing this book is to educate investors on how to derive an accurate valuation of a company prior to buying or selling its shares.